Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure

Circulation

Volumn 114, Issue 20, 2006, Pages 2130-2137

  Tuunanen, Helena ^a   Engblom, Erik ^a   Naum, Alexandru ^a   Någren, Kjell ^a   Hesse, Birger ^c   Airaksinen, K E Juhani ^a   Nuutila, Pirjo ^a   Iozzo, Patricia ^a,d   Ukkonen, Heikki ^a   Opie, Lionel H ^b   Knuuti, Juhani ^a,e  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Rigshospitalet   (Denmark)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e TURKU PET CENTRE   (Finland)

Author keywords

Cardiomyopathy; Fatty acids; Heart failure; Metabolism

Indexed keywords

ACETIC ACID; ACIPIMOX; FATTY ACID; HYDROGEN PEROXIDE; PALMITIC ACID;

ADULT; AEROBIC METABOLISM; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART STROKE VOLUME; HEART WORK; HUMAN; LIPOLYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ANTILIPEMIC AGENTS; CARDIAC OUTPUT, LOW; CARDIOMYOPATHY, DILATED; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXIDATION-REDUCTION; POSITRON-EMISSION TOMOGRAPHY; PYRAZINES; VENTRICULAR FUNCTION, LEFT;

EID: 33751002633     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.645184     Document Type: Article

References (36)

1. Opie LH. Fuels: aerobic and anaerobic metabolism. In: Weinberg RWSK, ed. The Heart Physiology, from Cell to Circulation. Philadelphia: Lippincott-Raven Publishers; 1998:295-341.
2. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
3. Knuuti MJ, Maki M, Yki-Jarvinen H, Voipio-Pulkki LM, Harkonen R, Haaparanta M, Nuutila P. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol. 1995;27:1359-1367.
4. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
5. Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation. 2004;110:955-961.
6. Lee L, Campbell R, Scheuermann-Freestone M, Taylor R, Gunaruwan P, Williams L, Ashrafian H, Horowitz J, Fraser AG, Clarke K, Frenneaux M. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation. 2005;112:3280-3288.
7. Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J. 2004;25:1814-1821.
8. How OJ, Aasum E, Kunnathu S, Severson DL, Myhre ES, Larsen TS. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts. Am J Physiol Heart Circ Physiol. 2005;288:H2979-H2985.
9. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. Lancet. 2004;19:364:1786-1788.
10. Wallhaus TR, Taylor M, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation. 2001;103:2441-2446.
11. Bengel FM, Permanetter B, Ungerer M, Nekolla S, Schwaiger M. Noninvasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate: comparison between the normal and failing human heart. Eur J Nucl Med. 2000;27:319-326.
12. Beanlands RS, Bach DS, Raylman R, Armstrong WF, Wilson V, Montieth M, Moore CK, Bates E, Schwaiger M. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1993;22:1389-1398.
13. Beanlands RS, Armstrong WF, Hicks RJ, Nicklas J, Moore C, Hutchins GD, Wolpers HG, Schwaiger M. The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy. J Nucl Cardiol. 1994;1:3-16.
14. Sochor H, Schelbert HR, Schwaiger M, Henze E, Phelps ME Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med. 1986;12(suppl):S66-S69.
15. Schelbert HR, Henze E, Sochor H, Grossman RG, Huang SC, Barrio JR, Schwaiger M, Phelps ME. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J. 1986;111:1055-1064.
16. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24:362-365.
17. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001;48:81-86.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echo-cardiographic measurements. Circulation. 1978;58:1072-1083.
19. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
20. Knuuti J, Takala TO, Nagren K, Sipila H, Turpeinen AK, Uusitupa MI, Nuutila P. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia. 2001;44:184-187.
21. Pike VW, Eakins MN, Allan RM, Selwyn AP. Preparation of [1-11C]acetate: an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 1982;33:505-512.
22. Padgett HC, Robinson GD, Barrio JR. [1-(11)C]palmitic acid: improved radiopharmaceutical preparation. Int J Appl Radiat Isot. 1982;33:1471-1472.
23. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 1995;36:78-85.
24. Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 1992;33:1669-1677.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
26. Marbach EP, Weil MH. Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant. ClinChem. 1967;13:314-325.
27. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837-2842.
28. Wiggers H, Norrelund H, Nielsen SS, Andersen NH, Nielsen-Kudsk JE, Christiansen JS, Nielsen TT, Moller N, Botker HE. Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. Am J Physiol Heart Circ Physiol. 2005;289:H938-H946.
29. Witteles RM, Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB. Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link. J Am Coll Cardiol. 2004;44:78-81.
30. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJ. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527-532.
31. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191-2196.
32. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 1999;13:805-812.
33. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R. Defective lipolyis and altered energy metabolism in mice lacking adipose tissue triglyceride lipase. Science. 2006;312:734-737.
34. Davila-Roman VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271-277.
35. Morrow DA, Givertz MM. Modulation of myocardial energetics: emerging evidence for a therapeutic target in cardiovascular disease. Circulation. 2005;112:3218-3221.
36. Taegtmeyer H. Metabolism: the lost child of cardiology. J Am Coll Cardiol. 2000;36:1386-1388.